Scientist Adedokun is affiliated with the Departments of Immunology and Cell Stress at Roswell Park Comprehensive Cancer Center (RPCCC), USA. He has made significant contributions to biomedical research, with more than 50 peer-reviewed publications and over 4,000 citations. His scholarly contributions include publications in internationally recognized journals such as Nature Medicine and The Lancet, as well as multiple book chapters published by leading academic publishers, including Elsevier and Wiley. His current research focuses on cancer immunotherapy and the development of next-generation radioimmunotherapy approaches for aggressive and metastatic cancers, with particular emphasis on immune-modulatory pathways involving Toll-like receptor 5 (TLR5) and the NAIP5/NLRC4 inflammasome. Beyond his research contributions, Scientist Adedokun actively serves the global scientific community through peer review and editorial activities in cancer biology, immunology, and biomedical sciences. He has completed more than 200 peer-review assignments for over 50 internationally recognized journals, including Scientific Reports (Nature Portfolio; Q1), Journal of Immunology (Oxford University Press), Cancer Letters (Impact Factor 11.8; Q1), Science Bulletin (Impact Factor 20.7; Q1), Advanced Science (Wiley; Impact Factor 14.1; Q1), MedComm (Wiley; Impact Factor 14.1; Q1), iScience (Cell Press; Q1), PLOS ONE, BMC Infectious Diseases (Springer Nature), Advances in Radiation Oncology, etc